- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | KNOW LABS, INC. - 8-K, Current Report | - | SEC Filings | ||
| Di | Know Labs stock hits 52-week low at $0.18 amid market challenges | 3 | Investing.com | ||
| KNOW LABS Aktie jetzt für 0€ handeln | |||||
| 13.12. | Know Labs announces $300K registered direct offering | 1 | Seeking Alpha | ||
| 13.12. | Know Labs preist Direktplatzierung bei 0,24 US-Dollar pro Einheit | 2 | Investing.com Deutsch | ||
| 13.12. | Know Labs prices direct offering at $0.24 per unit | 2 | Investing.com | ||
| 11.12. | Know Labs gets extension to meet NYSE American standards | 1 | Investing.com | ||
| 11.12. | Know Labs announces NYSE American acceptance of plan to regain compliance | 1 | Seeking Alpha | ||
| 11.12. | Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance | 20 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that on December 10, 2024, it received notification (the... ► Artikel lesen | |
| 18.11. | Know Labs Provides Overview of FY2024 10-K Annual Report | 60 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its... ► Artikel lesen | |
| 15.11. | Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results | 98 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and... ► Artikel lesen | |
| 14.11. | KNOW LABS, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 30.10. | Know Labs expands stock authorization and equity plan | 1 | Investing.com | ||
| 30.10. | KNOW LABS, INC. - 8-K, Current Report | - | SEC Filings | ||
| 28.10. | Know Labs extends debt maturity, raises interest rate | 1 | Investing.com | ||
| 11.10. | Know Labs-Aktie erreicht 52-Wochen-Tief bei 0,23 US-Dollar | 1 | Investing.com Deutsch | ||
| 02.10. | Know Labs faces NYSE American non-compliance notice | 2 | Investing.com | ||
| 02.10. | Know Labs erhält Non-Compliance-Mitteilung der NYSE American | 3 | Investing.com Deutsch | ||
| 02.10. | Know Labs announces notification of noncompliance with NYSE American continued listing standards | 1 | Seeking Alpha | ||
| 02.10. | Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards | 80 | Business Wire | SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) (the "Company" or "Know Labs"), a leading developer of non-invasive diagnostics technology, announced today that it received a notice... ► Artikel lesen | |
| 27.09. | Know Labs bestätigt Wirtschaftsprüfer und Vorstandswahlen | 1 | Investing.com Deutsch |
Seite:
1 2 Weiter >>
39 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| LIFEMD | 5,040 | 0,00 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| TEMPUS AI | 35,500 | 0,00 % | Tempus AI's (TEM) AI-Powered Healthcare Revolution: What's Next? | ||
| FRESENIUS | 33,200 | 0,00 % | Fresenius SE Aktie: Neue Möglichkeiten erobern den Markt! | Die Fresenius SE-Aktie verzeichnete im XETRA-Handel einen spürbaren Rückgang von 1,9 Prozent auf 32,84 EUR. Während der Handelssitzung bewegte sich der Kurs zwischen einem Tageshoch von 33,29 EUR und... ► Artikel lesen | |
| GERRESHEIMER | 70,00 | +3,47 % | EQS-News: Gerresheimer AG: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU* | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Zulassungsantrag
Gerresheimer: FDA erteilt "Tentative Approval" für Lasix von SQ Innovation® ONYU*
16.12.2024 / 09:00... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 51,94 | -0,31 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers in einer Vorschau auf die Zahlen des ersten Quartals auf "Overweight" mit einem Kursziel von 65,90 Euro... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,390 | +1,16 % | Neue 9,50% Aktienanleihe mit Barriere auf Fresenius Medical Care in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VC95GD8/ WKN VC95GD) mit Barriere auf die Aktie von Fresenius... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 17,260 | 0,00 % | BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 14,350 | 0,00 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| RXSIGHT | 33,650 | 0,00 % | RxSight cut to hold at Stifel on competition concerns | ||
| PROCEPT BIOROBOTICS | 81,25 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ADAPTHEALTH | 10,305 | 0,00 % | AdaptHealth Corp. Announces Third Quarter 2024 Results | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 45,860 | +0,13 % | Carl Zeiss Meditec: Chance auf Gegenbewegung! | Im Express-Service vom 27. November hatten wir geschrieben: "Bei Carl Zeiss Meditec schlagen wir den Einstieg ab 59,00 Euro vor. Bei steigendem Handelsvolumen sollte der Anstieg über die 60-Euro-Marke... ► Artikel lesen | |
| GENEDX | 77,33 | 0,00 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| CLEARPOINT NEURO | 15,545 | 0,00 % | ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain | Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the... ► Artikel lesen |
Das Unternehmen KNOW LABS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,139 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KNOW LABS INC finden Sie auf Wallstreet Online.
